Zimmer Biomet (ZBH) reported $8.2B in revenue for fiscal 2025, +7.2% year on year. That ranks #573 by revenue among 2853 SEC filers and #58 in Healthcare. Net income was $705M, a net margin of 8.6%. Revenue has grown 0.8% a year on average since 2016 ($7.7B then). The fiscal 2025 balance sheet shows $23.1B in total assets, $592M in cash and $6.9B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $8.2B | +7.2% | FY20252025-12-31 |
| Gross profitGrossProfit | $3.4B | +2.6% | FY20142014-12-31 |
| Operating incomeOperatingIncomeLoss | $1.1B | −14.6% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $705M | −22.0% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $1.7B | +13.2% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $225M | +10.2% | FY20252025-12-31 |
| Total assetsAssets | $23.1B | +8.1% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $12.7B | +1.8% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $592M | +12.6% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $6.9B | +29.8% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $2.1B | $238M | Open → |
| Q2 20262026-06-30 | $2.2B | $198M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 65 of 161 companies compared | 8.6% | |
| Operating marginRank 64 of 160 companies compared | 13.3% | |
| R&D as share of revenueRank 73 of 102 companies compared | 5.6% | |
| Cash as share of revenueRank 108 of 160 companies compared | 7.2% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Zimmer Biomet Holdings, Inc.
- Ticker
- ZBH
- Exchange
- NYSE
- SIC classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- Fiscal year end
- 12-31
- CIK
- 0001136869
Filings
- 10-QAug 5, 2026Open filing →
- 10-QMay 1, 2026Open filing →
- 10-KFeb 20, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| ZoetisZTS | $9.5B | $2.7B |
| SolventumSOLV | $8.3B | $1.6B |
| IconICLR | $8.3B | $229M |
| Zimmer BiometZBH | $8.2B | $705M |
| Ardent HealthARDT | $6.3B | $136M |
| OrganonOGN | $6.2B | $187M |
| Smith & NephewSNN | $6.2B | $625M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Zimmer Biomet — Key figures |url=https://companiesranked.com/en/company/zimmer-biomet |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Zimmer Biomet — Key figures. CompaniesRanked. https://companiesranked.com/en/company/zimmer-biometBibTeX
@misc{companiesranked-en-company-zimmer-biomet-2026,
author = {{CompaniesRanked}},
title = {{Zimmer Biomet — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/zimmer-biomet}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-059853 · February 20, 2026
{{cite web |title=Zimmer Biomet — Key figures — 10-K (0001193125-26-059853) |url=https://www.sec.gov/Archives/edgar/data/1136869/000119312526059853/zbh-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-20}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.